Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Sapienza, A. Falcone, R.
The Role of Trust in COVID-19 Vaccine Acceptance: Considerations from a Systematic Review
All age groups COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Ou, L. Youngstedt, S. D.
The Role of Vaccination Interventions to Promote HPV Vaccine Uptake Rates in a College-Aged Population: a Systematic Review
Adults Human papillomavirus (HPV) Coverage Acceptance
Rating:
Not applicable
2022 ∙ Zou, Y. Huang, D. Jiang, Q. Guo, Y. Chen, C.
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Petrelli, F. Luciani, A. Borgonovo, K. Ghilardi, M. Parati, M. C. Petrò, D. Lonati, V. Pesenti, A. Cabiddu, M.
Third Dose of SARS-CoV-2 Vaccine: A Systematic Review of 30 Published Studies
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Critically low
2022 ∙ Mani, Avinash Ojha, Vineeta
Thromboembolism after Covid-19 vaccination: a systematic review of such events in 286 patients
Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Kim, Ah Young Woo, Wongi Yon, Dong Keon Lee, Seung Won Yang, Jae Won Kim, Ji Hong Park, Seoyeon Koyanagi, Ai Kim, Min Seo Lee, Sungsoo Shin, Jae Il Smith, Lee
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Saluja, Prachi Gautam, Nitesh Yadala, Sisira Venkata, Anand N.
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases
Adolescents Adults Older adults COVID-19 Safety Administration
Rating:
Critically low
2022 ∙ Caironi, V. Pitoia, F. Trimboli, P.
Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Lei, D. Miller, T. Carr, J. Buttery, J. Nold-Petry, C. A. Nold, M. F. Malhotra, A.
Timing of the First Dose of the Hepatitis B Vaccine in Preterm Infants
Newborn Hepatitis B Efficacy/effectiveness Safety
Rating:
Critically low
2022 ∙ Mathew, M. Thomas, J.
Tobacco-Based Vaccines, Hopes, and Concerns: A Systematic Review
All age groups Economic aspects
Rating:
Not applicable
Loading...